Drug Discovery Product Showcase
-
GenVoy-ILM™: Power To Explore
4/14/2022
GenVoy-ILM is a pre-optimized lipid mixture designed to encapsulate RNA – mRNA, gRNA, siRNA, miRNA, tRNA – in LNP.
-
NanoAssemblr® Spark™: Freedom To Discover
4/14/2022
The NanoAssemblr® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.
-
ÄKTA oligosynt™ Oligonucleotide Synthesizer
3/28/2022
The ÄKTA oligosynt™ oligonucleotide synthesizer is a compact, fully automated oligonucleotide synthesizer built for research and process development laboratories. The system supports a robust and easily scalable oligonucleotide synthesis process and transfer to larger oligonucleotide synthesizers with high yield and quality.
-
Accelerator℠ Integrated Platform Solution for Adherent Lentivirus (LV)
3/25/2022
Learn more about our end-to-end process support, from development to industrialization with a set of scalable solutions for lentivirus production.
-
Adeno-Associated Virus (AAV) Manufacturing: A Scalable, Integrated Solutions Adherent Platform Approach
3/10/2022
In process development, speed to market and costs are critical considerations. Learn more about the Pall products and services that can help you throughout your drug commercialization journey - from development and manufacture, right through to the regulatory approval of AAV based therapies.
-
Palltronic® Flowstar V Integrity Test Instrument
3/10/2022
Filter integrity testing reaches a whole new level with the Palltronic Flowstar V featuring higher safety margins with a plug-and-play network integration.
-
Instrument For Accurate Filter Integrity Testing
3/10/2022
The Palltronic Flowstar V integrity test instrument ensures accurate filter integrity testing with a further reduction in test time, full compliance with 21 CFR Part 11, advanced automation capabilities, and simplified network integration saving the user time while improving process efficiency.
-
Mustang Q XT Chromatography Capsules
3/10/2022
These capsules are reliable, easy to use and enable users to significantly improve their process economics through reduced buffer consumption, increased throughput and reduced capital expenditure.
-
The Fast Track To IND
2/24/2022
Our service package brings together cell line development (CLD) to accelerate your program and puts your molecule on the path to success.
-
Increase Success In Drug Discovery While Reducing Time And Cost With RepliGut®
2/24/2022
Reduce the time and cost of drug development with a platform that more accurately reflects native human biology and reduces the need for animal testing.